Clinical trials
Phase 2/3 Stroke trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2016 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acticor Biotech | 1 |
| Boston Scientific Corporation | 1 |
| Max-Planck-Institute of Experimental Medicine | 1 |
| University Hospital Muenster | 1 |
| University of Cologne | 1 |
| Wilhelm Haverkamp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 6 |
| Aphasia | 1 |
| Atrial Fibrillation | 1 |
| Hypoxia | 1 |
| Infarction, Middle Cerebral Artery | 1 |
| Ischemia | 1 |
| Ischemic Attack, Transient | 1 |
| Ischemic Stroke | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.